Tony Chan

Partner

Washington, D.C.

Boston

New York

Tony’s practice focuses on advising companies and investors in the life sciences and tech sectors on strategic domestic and cross-border corporate transactions.

Tony regularly advises clients on mergers and acquisitions (M&A), private equity, growth equity, and venture capital transactions, as well as on corporate governance, joint ventures and corporate finance.

His clients include global strategic buyers and sellers, as well as financial sponsors and their portfolio companies in the life science, healthcare, investment management, technology and video game industries.

Tony has been recognized for his life sciences and M&A work by a number of notable publications, including The Legal 500 US, Law360, IFLR1000 and Legal Media Group. In particular, Law360 highlighted his work in navigating the complex life sciences industry and key partnership negotiations between biotechnology and drug companies.

In addition, Tony sustains an active pro bono practice, serving as counsel to nonprofit organizations such as Aequitas, APAI Vote, Chefs Stopping Asian American Hate, Rebuilding Together Philadelphia, the Philadelphia Film Society, and the Harvard Asian Alumni Alliance. Tony also serves as an adjunct professor at Georgetown Law School where he has taught Takeovers, Mergers and Acquisitions since 2015.

  • Technology

    • Accel in the $200 million Series E financing of Axonius, a provider of cybersecurity asset management solutions
    • Smash Ventures in a $690 million investment in Coda Payments, the world's leading independent platform for digital content monetization based in Singapore
    • Smash Ventures in the $175 million Series C financing of Wagestream, the provider of a financial well-being app for frontline workers*
    • Glade Brook Capital Partners in the $63 million Series C financing of Facily, a São Paulo-based social commerce marketplace*
    • Glade Brook Capital Partners in the $36 million Series CB+ financing of Fenbeitong, a Chinese business expense management startup*
    • Glade Brook Capital Partners in the 100 million financing of Good Eggs, a grocery delivery service that specializes in locally sourced products*
    • Glade Brook Capital Partners in the $175 million Series G financing of Hopper, the world's fastest-growing mobile-first travel marketplace*
    • Glade Brook Capital Partners in a $125 million financing of Betterfly, a Chilean insurance-tech startup*
    • Glade Brook Capital Partners in a $60 million Series A financing of Kiranakart Technologies Pvt Ltd, which runs Zepto, an India-based 10-minute grocery delivery app*
    • Glade Brook Capital Partners in the $30 million Series B financing of Headout, an online experience marketplace for travelers*
    • Smash Ventures in its investment in DuckDuckGo, a privacy company that provides mobile browser and desktop extensions that allow private searches and seamless trackers for someone browsing online*
    • Stripes Group in the $60 million financing of Caronsale, the berlin-based car marketplace*
    • Stripes Group in the $100 million Series D financing of Axonius, a provider of cybersecurity asset management solutions*
    • Stripes Group in the $50 million financing of Sift, a fraud prevention provider that uses machine learning and artificial intelligence*
    • Stripes Group in the $133 million Series C financing of Fireblocks, a crypto infrastructure provider*
    • Stripes Group in the $60 million Series C financing of Rapid API, a company that has built a marketplace that enables millions of developers to discover, test and connect to thousands of Application Programming Interfaces so they can build applications faster*
    • Smash Ventures in its investment in BYJU, an India edtech company*
    • Glade Brook Capital Partners in the $100 million Series H financing in VerSe Innovation, the parent company of Dailyhunt, an Indian content and news aggregator application*
    • ARInsights, a provider of SaaS solutions and data to the analyst relations industry, in the strategic investment from Polaris Growth Fund*
    • Stripes Group, a leading growth investor, in the $100 million Series D financing of Dataiku, a company focused on AI and machine learning platforms, supporting agility in organizations’ data efforts via collaborative, elastic, and responsible AI, all at enterprise scale*
    • Stripes Group in the $22 million Series B financing of Legion, an AI-powered workforce management solution that simultaneously drives labor efficiency and employee engagement*
    • ARInsights, a provider of SaaS solutions and data to the analyst relations industry, in the strategic investment from Polaris Growth Fund*
    • Mirae Asset Global Investments in a $500 million financing of Impossible Foods, a company that develops plant-based substitutes for meat products with a much smaller environmental impact*
    • Mirae Asset Global Investments in a $210 million financing of FalconX, a digital assets and cryptocurrency financial services company that provides institutions trading, credit, and clearing across major cryptocurrencies*
    • Mirae Asset Global Investments in a $270 million financing of Cohere, a Canada based company that developed a natural language processing software
    • Mirae Asset Global Investments in its investment in X Holdings, Inc. in connection with its acquisition of Twitter, Inc.
    • Mirae Asset Global Investments in its $100 million financing of SpaceX, a California based company that is the developer of rockets and spacecraft designed to realize the goal of making life multi-planetary
    • Mirae Asset Global Investments in its $360 million financing for Animonca Brands
    • Mirae Asset Global Investments in its $260 million Series B financing of JOKR
    • Stripes in a Series B investment in Verbit, a provider of a transcription and captioning platform leveraging artificial intelligence to generate detailed speech-to-text files*
    • Stripes in a $150 million financing of Snyk, a company that helps developer organizations find and fix vulnerabilities in their code*
    • Stripes in a $32 million Series C Preferred Stock financing of FullStory, a developer of software tools designed to capture customer experience data*
    • Stripes in multiple financings of Remitly, an online international payments company, including the most recent $220 million Series E financing*
    • Stripes in a $25 million Series B financing of BacklotCars, an online marketplace for automotive sales*
    • Stripes in a $30 million Series B financing of HyperScience, a company that creates AI-centered enterprise solutions for automating work*
    • Stripes in a $15 million financing of Remine, which offers real estate intelligence to agents through its platform that analyzes property records, transaction history, consumer data and delivers opportunities on an intuitive user interface*
    • Stripes in a $53 million financing of Sift Sciences, the leading provider of fraud prevention and risk management solutions using real-time machine learning*
    • Turtle Beach Corporation, a global gaming accessory manufacturer based in San Diego, California, in its acquisition of ROCCAT, a developer of innovative, award-winning gaming mice, keyboards and other accessories, and Neat Microphones, makers of desktop USB microphones*
    • Glade Brook Capital Partners in a $50 million Series I Preferred Share investment in Zomato Media, an online platform for restaurant discovery and delivery*
    • Glade Brook Capital Partners in a $450 million investment in Miss Fresh, an e-commerce company that delivers fresh produce in 20 Chinese cities*
    • Smash Ventures in its investments in Epic Games, the publisher of Fortnite, NOBULL, a footwear, apparel, and accessory brand, and Manscaped*
    • Companies in the video game industry in a wide variety of matters, including licensing, distribution, development, supply, manufacturing, co-promotion, sponsorship, e-sports and influencer agreements, as well as with respect to IP, data protection and regulatory compliance*

    Life Sciences

    • Ipsen in its acquisition of Epizyme, a commercial-stage biopharmaceutical company developing therapies for cancer
    • Ipsen in its acquisition of Albireo, a leading innovator in bile-acid modulators to treat liver disease
    • Euclid Vision Systems, a global leader in specialty contact lenses, in its acquisitions of (i) Ennovy Group Limited, a UK-based company that manufactures premium bespoke contact lenses; (ii) Acuity Polymers, a specialty contact lens materials company; and (iii) Visionary Optics, a custom contact lens company that focuses on scleral lenses
    • Stripes in a $70 million Series D investment in Hello Heart, a mobile app that uses AI, behavioral sciences and personalized digital coaching to empower people to embrace healthier behaviors
    • Kain Capital in its investment in MY DR NOW, Arizona's largest privately owned primary care group
    • Kain Capital on its acquisition of HospiceServe
    • Mirae Asset Global Investments in its investment in the (i) $150 million Series B financing of Septerna, an operator of a biotechnology company intended to provide novel small molecule medicines targeting g-protein-coupled receptors; (ii) US$85 million Series B financing of Ensoma, an operator of a biotech company intended to develop genomic medicine, pioneering a next-generation in vivo approach for treatment; (iii) equity financing of Rome Therapeutics, a company discovering new classes of medicines for cancer and auto immune diseases; and (iv) Series C financing of Generate Biomedicines, a company using machine learning, bioengineering and medicine to find breakthroughs
    • Kain Capital in its investment in MindColor Autism Group, a company that provides Applied Behavior Analysis therapy to help improve the lives of children and families impacted by autism*
    • North America Science Associates, Inc., the first independent company in the world to focus solely on testing medical device materials for safety, in its sale of a majority interest to ArchiMed*
    • Celgene Corporation on its acquisition of Avila Therapeutics for up to $925 million, and investments in biotechnology companies, including Jounce, Juno, Nurix, Sutro BioPharma, Forma, Oncomed and Epizyme*
    • Ipsen in connection with its acquisition of global oncology assets from Merrimack Pharmaceuticals for up to $1 billion*
    • Ferring Pharmaceuticals on its purchases of Cytokine PharmaSciences and Controlled Therapeutics and its acquisitions of Lysteda from Xanodyne Pharmaceuticals; DDAVP from Sanofi; Milprosa from Teva Women’s Health and orthobiologic product candidates from BioSurface Engineering Technologies*
    • Kain Capital in its acquisition of occupational medicine clinics, including ProCare Work Injury Center, a clinic located in southern California*
    • R-Pharm in its acquisition of Ixempra from Bristol-Myers Squibb*

    Financial Services

    • NextCapital Group, an open-architecture digital advice provider, on its acquisition by Goldman Sachs
    • Global X, a New York-based sponsor of thematic exchange-traded funds, in a joint venture with Tokyo-based Daiwa Securities Group, Japan’s second largest brokerage house, and Daiwa Asset Management to expand access to intelligent outcome-oriented ETFs for Japanese investors and a related $120 million convertible note investment*
    • Wasmer, Schroeder & Company, LLC, a fixed-income investment manager, in its sale to The Charles Schwab Corporation*
    • South Korea-based Mirae Asset Global Investments in its acquisition of Global X Management Company, a sponsor of thematic, income and international exchange-traded funds*
    • Guggenheim Investments in its acquisition of Accretive Asset Management*

    *Matter handled prior to joining Orrick